Aniket Bankar, MD, discusses why rusfertide is considered a promising therapeutic approach for patients with polycythemia vera.

Investigators added more data to an analysis first published in 2020 and got the same result: ruxolitinib beats other ...

In patients with renal insufficiency associated with increased hemoglobin levels and polycythemia, the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and ...

Protagonist Therapeutics has 2 attractive late-stage pipeline assets, but commercialized sales will not begin until 2027.

Hence, just like low haemoglobin levels (less than 13.2 g/dL for men and 11.6 g/dL for women) necessitate medical ...

Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of ...

Testosterone. Even the word alone sounds manly. For men, testosterone is important for drive, fertility, heart health, bone ...

There is controversy over the diagnostic criteria, with one proposed definition placing it at the center of many other ...

Gateway Investment Advisers LLC lessened its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 8.5% during the ...

After hours: October 11 at 6:57 PM EDT Loading Chart for PTGX ...

After hours: October 11 at 4:22 PM EDT Loading Chart for IRON ...

Global Myeloproliferative Disorders Drugs Market is expanding at a significant growth rate due to advancements in targeted therapies, increasing prevalence of myeloproliferative disorders, growing ...